<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="antithesis" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">2. Obesity</segment>
<segment id="2" parent="1002" relname="preparation">Before Liver Transplantation</segment>
<segment id="3" parent="1002" relname="joint">2.1 .</segment>
<segment id="4" parent="1002" relname="joint">How Should Obesity be Defined in Patients with Cirrhosis Considered for LT ?</segment>
<segment id="5" parent="1005" relname="span">The first obstacle is to define obesity in this population .</segment>
<segment id="6" parent="5" relname="elaboration">Elamparast et al. recently summarized the most commonly used definitions in this group of patients :</segment>
<segment id="7" parent="1008" relname="span">- BMI ≥ 30 kg/m2</segment>
<segment id="8" parent="9" relname="preparation">( Asian population :</segment>
<segment id="9" parent="1009" relname="span">≥25 kg/m2 ) ;</segment>
<segment id="10" parent="1008" relname="elaboration">-</segment>
<segment id="11" parent="1011" relname="span">Percentage of fat mass ≥28 % in men and ≥40 % in women ;</segment>
<segment id="12" parent="1012" relname="span">- Waist circumference ˃102 cm in men and ˃88 cm in women</segment>
<segment id="13" parent="1014" relname="preparation">( Asian population :</segment>
<segment id="14" parent="1014" relname="joint">A waist circumference ˃90 cm in men and ˃80 cm in women ) ;</segment>
<segment id="15" parent="1014" relname="joint">- Visceral fat area ≥100 cm2 on abdominal computed tomography .</segment>
<segment id="16" parent="1016" relname="span">The use of BMI has several limitations in patients with decompensated cirrhosis ,</segment>
<segment id="17" parent="1017" relname="span">as reflected by the fact</segment>
<segment id="18" parent="17" relname="elaboration">that sarcopenia outperforms BMI as a predictor of outcomes after LT .</segment>
<segment id="19" parent="1019" relname="span">First of all , a high BMI may be due to fluid overload/ascites , and not obesity per se ,</segment>
<segment id="20" parent="1021" relname="span">as exemplified in a study</segment>
<segment id="21" parent="1022" relname="span">in which adjusting BMI for the liters of ascites</segment>
<segment id="22" parent="21" relname="elaboration">drained at the time of LT</segment>
<segment id="23" parent="1021" relname="elaboration">resulted in moving one-fifth of patients from one BMI category to a lower one .</segment>
<segment id="24" parent="1024" relname="span">Also , BMI gives no information about body composition :</segment>
<segment id="25" parent="1025" relname="span">It cannot tell the difference between muscle , subcutaneous , or visceral adipose tissue ,</segment>
<segment id="26" parent="25" relname="elaboration">which have different implications .</segment>
<segment id="27" parent="1027" relname="span">Studies looking at body composition on cross-sectional imaging</segment>
<segment id="28" parent="29" relname="attribution">have found</segment>
<segment id="29" parent="1028" relname="span">that sarcopenia and low subcutaneous adipose tissue , but not BMI , are associated with mortality in male and female patients with cirrhosis , respectively .</segment>
<segment id="30" parent="1030" relname="span">Excessive visceral fat</segment>
<segment id="31" parent="1031" relname="joint">when associated with sarcopenia , a term known as sarcopenic obesity ,</segment>
<segment id="32" parent="1031" relname="joint">is also associated with increased mortality .</segment>
<segment id="33" parent="1034" relname="span">In the case of living donor liver transplant</segment>
<segment id="34" parent="33" relname="elaboration">( LDLT )</segment>
<segment id="35" parent="1033" relname="same_unit">patients , sarcopenia , myosteatosis , and the visceral-to-subcutaneous-adipose-tissue ratio , but not visceral or subcutaneous tissue on their own , have been associated with mortality .</segment>
<segment id="36" parent="1036" relname="span">This reinforces the fact</segment>
<segment id="37" parent="1037" relname="span">that more than the size of a patient ,</segment>
<segment id="38" parent="1038" relname="span">which is what the BMI stands for ,</segment>
<segment id="39" parent="1039" relname="span">it is the composition</segment>
<segment id="40" parent="39" relname="elaboration">that matters .</segment>
<segment id="41" parent="1042" relname="span">For the same reasons ,</segment>
<segment id="42" parent="1043" relname="span">waist circumference is not the best method</segment>
<segment id="43" parent="42" relname="purpose">to assess obesity in these patients .</segment>
<segment id="44" parent="1044" relname="span">Trying to circumvent some of these limitations ,</segment>
<segment id="45" parent="1046" relname="span">the European Association for the Study of the Liver guidelines for nutrition in patients with cirrhosis recommend to adjust the BMI for the confounding effect of fluid retention</segment>
<segment id="46" parent="45" relname="elaboration">( i. e. , dry-BMI ) ,</segment>
<segment id="47" parent="1048" relname="circumstance">though there is no perfect correlation between BMI and ascites ,</segment>
<segment id="48" parent="1048" relname="span">and in fact , BMI</segment>
<segment id="49" parent="1049" relname="span">corrected for ascites</segment>
<segment id="50" parent="49" relname="elaboration">drained at the time of LT failed to predict relevant outcomes after LT .</segment>
<segment id="51" parent="1054" relname="span">Likewise , a modified BMI</segment>
<segment id="52" parent="51" relname="elaboration">calculated</segment>
<segment id="53" parent="1055" relname="span">by multiplying BMI</segment>
<segment id="54" parent="53" relname="restatement">( kg/m2 )</segment>
<segment id="55" parent="1057" relname="span">by serum albumin</segment>
<segment id="56" parent="55" relname="restatement">( g/L )</segment>
<segment id="57" parent="1058" relname="span">with the intention</segment>
<segment id="58" parent="57" relname="elaboration">of compensating for volume overload</segment>
<segment id="59" parent="1059" relname="span">was found of no use</segment>
<segment id="60" parent="59" relname="purpose">to predict clinical outcomes .</segment>
<segment id="61" parent="1061" relname="same_unit">In conclusion ,</segment>
<segment id="62" parent="1063" relname="attribution">when available , we suggest</segment>
<segment id="63" parent="1063" relname="span">obesity be defined</segment>
<segment id="64" parent="65" relname="attribution">according to the visceral fat area on body composition analysis , especially in the research setting ,</segment>
<segment id="65" parent="1064" relname="span">because the impact of obesity on LT may be modified by the coexistence of sarcopenia , myosteatosis , and/or low subcutaneous adipose tissue .</segment>
<segment id="66" parent="1035" relname="joint">2.2 .</segment>
<segment id="67" parent="1035" relname="joint">Should Morbidly Obese Patients be Listed for LT ?</segment>
<segment id="68" parent="1068" relname="span">Some LT programs consider morbid obesity a relative contraindication for LT</segment>
<segment id="69" parent="68" relname="elaboration">based on the latest recommendations from the American Association for the Study of the Liver .</segment>
<segment id="70" parent="1070" relname="span">However , evidence</segment>
<segment id="71" parent="70" relname="elaboration">evaluating the role of obesity on outcomes after LT is conflicting .</segment>
<segment id="72" parent="1072" relname="span">When needed ,</segment>
<segment id="73" parent="1073" relname="span">patients with severe and morbid obesity do benefit from LT ,</segment>
<segment id="74" parent="1076" relname="span">meaning they live longer</segment>
<segment id="75" parent="74" relname="antithesis">than they would do without it ,</segment>
<segment id="76" parent="1075" relname="joint">and LT in these patients strays far away from being futile ,</segment>
<segment id="77" parent="1074" relname="joint">with five-year survival rates well above 50 % .</segment>
<segment id="78" parent="1078" relname="span">Evidence so far does not support</segment>
<segment id="79" parent="1080" relname="span">using a strict BMI cutoff</segment>
<segment id="80" parent="79" relname="purpose">to deny someone candidacy for LT ,</segment>
<segment id="81" parent="1081" relname="span">however obesity is frequently associated with other conditions</segment>
<segment id="82" parent="81" relname="elaboration">that may be contraindications for LT such as cardiovascular disease , cancer , renal dysfunction , and pulmonary hypertension .</segment>
<segment id="83" parent="1083" relname="span">Also , obesity is a risk factor for NAFLD ,</segment>
<segment id="84" parent="1084" relname="span">which though traditionally considered to have similar post-LT outcomes to those of other etiologies of liver disease ,</segment>
<segment id="85" parent="1085" relname="span">may in fact have lower one-year survival</segment>
<segment id="86" parent="85" relname="elaboration">due to cardiovascular and cerebrovascular diseases .</segment>
<segment id="87" parent="1069" relname="joint">In summary , more than obesity itself ,</segment>
<segment id="88" parent="1088" relname="span">it is the sum of the comorbidities of the individual patient</segment>
<segment id="89" parent="88" relname="elaboration">that determines LT outcomes</segment>
<segment id="90" parent="1090" relname="circumstance">and as such , morbid obesity should not be considered on its own a contraindication for LT ,</segment>
<segment id="91" parent="1091" relname="span">but in turn should trigger a rigorous pre-LT assessment</segment>
<segment id="92" parent="91" relname="purpose">to carefully select potential recipients ,</segment>
<segment id="93" parent="1090" relname="same_unit">as discussed below .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1001" relname="span"/>
<group id="1004" type="span" parent="1002" relname="joint"/>
<group id="1005" type="span" parent="1006" relname="preparation"/>
<group id="1006" type="multinuc" parent="1004" relname="span"/>
<group id="1007" type="span" parent="1006" relname="joint"/>
<group id="1008" type="span" parent="1007" relname="span"/>
<group id="1009" type="span" parent="7" relname="elaboration"/>
<group id="1011" type="span" parent="1006" relname="joint"/>
<group id="1012" type="span" parent="11" relname="elaboration"/>
<group id="1013" type="span" parent="12" relname="elaboration"/>
<group id="1014" type="multinuc" parent="1013" relname="span"/>
<group id="1016" type="span" parent="1006" relname="joint"/>
<group id="1017" type="span" parent="16" relname="elaboration"/>
<group id="1019" type="span" parent="1006" relname="joint"/>
<group id="1020" type="span" parent="19" relname="circumstance"/>
<group id="1021" type="span" parent="1020" relname="span"/>
<group id="1022" type="span" parent="20" relname="elaboration"/>
<group id="1024" type="span" parent="1006" relname="joint"/>
<group id="1025" type="span" parent="24" relname="elaboration"/>
<group id="1027" type="span" parent="1006" relname="joint"/>
<group id="1028" type="span" parent="27" relname="elaboration"/>
<group id="1030" type="span" parent="1006" relname="joint"/>
<group id="1031" type="multinuc" parent="30" relname="circumstance"/>
<group id="1032" type="multinuc" parent="1006" relname="joint"/>
<group id="1033" type="multinuc" parent="1032" relname="sequence"/>
<group id="1034" type="span" parent="1033" relname="same_unit"/>
<group id="1035" type="multinuc" parent="1032" relname="sequence"/>
<group id="1036" type="span" parent="1035" relname="joint"/>
<group id="1037" type="span" parent="36" relname="elaboration"/>
<group id="1038" type="span" parent="37" relname="elaboration"/>
<group id="1039" type="span" parent="38" relname="elaboration"/>
<group id="1041" type="span" parent="1035" relname="joint"/>
<group id="1042" type="span" parent="1041" relname="span"/>
<group id="1043" type="span" parent="41" relname="elaboration"/>
<group id="1044" type="span" parent="1042" relname="elaboration"/>
<group id="1045" type="multinuc" parent="44" relname="elaboration"/>
<group id="1046" type="span" parent="1045" relname="same_unit"/>
<group id="1047" type="span" parent="1045" relname="same_unit"/>
<group id="1048" type="span" parent="1047" relname="span"/>
<group id="1049" type="span" parent="48" relname="elaboration"/>
<group id="1051" type="multinuc" parent="1035" relname="joint"/>
<group id="1052" type="multinuc" parent="1051" relname="same_unit"/>
<group id="1053" type="span" parent="1052" relname="same_unit"/>
<group id="1054" type="span" parent="1053" relname="span"/>
<group id="1055" type="span" parent="1054" relname="means"/>
<group id="1056" type="multinuc" parent="1052" relname="same_unit"/>
<group id="1057" type="span" parent="1056" relname="same_unit"/>
<group id="1058" type="span" parent="1056" relname="same_unit"/>
<group id="1059" type="span" parent="1051" relname="same_unit"/>
<group id="1061" type="multinuc" parent="1035" relname="joint"/>
<group id="1062" type="span" parent="1061" relname="same_unit"/>
<group id="1063" type="span" parent="1062" relname="span"/>
<group id="1064" type="span" parent="63" relname="circumstance"/>
<group id="1067" type="multinuc" parent="1035" relname="joint"/>
<group id="1068" type="span" parent="1067" relname="contrast"/>
<group id="1069" type="multinuc" parent="1067" relname="contrast"/>
<group id="1070" type="span" parent="1069" relname="joint"/>
<group id="1072" type="span" parent="1069" relname="joint"/>
<group id="1073" type="span" parent="72" relname="elaboration"/>
<group id="1074" type="multinuc" parent="73" relname="elaboration"/>
<group id="1075" type="multinuc" parent="1074" relname="joint"/>
<group id="1076" type="span" parent="1075" relname="joint"/>
<group id="1078" type="span" parent="1069" relname="joint"/>
<group id="1079" type="span" parent="78" relname="means"/>
<group id="1080" type="span" parent="1081" relname="concession"/>
<group id="1081" type="span" parent="1079" relname="span"/>
<group id="1083" type="span" parent="1069" relname="joint"/>
<group id="1084" type="span" parent="83" relname="elaboration"/>
<group id="1085" type="span" parent="84" relname="elaboration"/>
<group id="1088" type="span" parent="1069" relname="joint"/>
<group id="1089" type="span" parent="1069" relname="joint"/>
<group id="1090" type="multinuc" parent="1089" relname="span"/>
<group id="1091" type="span" parent="1090" relname="same_unit"/>
	</body>
</rst>
